News

Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase ...
BP's second-quarter results will be hit by lower prices it received for its gas and oil, it said in a quarterly trading ...
The Dividend Harvesting Portfolio hit new all-time highs in value, profitability, and forward income. Learn more about the ...
JPY: From the low on July 1 near JPY142.70 through yesterday's high of almost JPY147.20, the dollar appreciated by slightly ...
Edition Adds AI-generated Customer Feedback Summaries and Platform GraphicsSTAMFORD, Conn., July 10, 2025 (GLOBE NEWSWIRE) -- BP ...